Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage

10 Aug 2020

Abstract excerpt

Abstract Introduction Exosomes are an emerging candidate for biomarkers of Alzheimer's disease (AD). This study investigated whether exosomal synaptic proteins can predict AD at the asymptomatic stage. Methods We conducted a two‐stage‐sectional study (discovery stage: AD, 28; amnestic mild cognitive impairment [aMCI], 25; controls, 29; validation stage: AD, 73; aMCI, 71; controls, 72), a study including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Extracellular vesicles in disease
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32776690
DOI: 10.1002/alz.12166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stagePMID 32776690Read ↗

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control studySemantic proximity Read ↗

Multiplex plasma profiling of synaptic biomarkers in Alzheimer’s disease using NULISA: early alterations, APOE genotype effects, and pTau217 associationsSemantic proximity Read ↗

Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseasesSemantic proximity Read ↗

Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s Disease patients and cognitively normal individualsSemantic proximity Read ↗

microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic PerspectiveSemantic proximity Read ↗

Assess Alzheimer’s Disease via Plasma Extracellular Vesicle-derived mRNASemantic proximity Read ↗

Cognitively Normal APOE ε4 Carriers Have Specific Elevation of CSF SNAP-25Semantic proximity Read ↗

Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSemantic proximity Read ↗

Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of AgingSemantic proximity Read ↗

SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s DiseaseSemantic proximity Read ↗

Extracellular Vesicles for Alzheimer’s Disease and Dementia DiagnosisSemantic proximity Read ↗

Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.